CLINICAL_TRIALS
trial_result
· 2012-05-30
Clinical Trial Update: Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage [Phase 2]
Summary
A Phase 2 clinical trial of belinostat (PXD101) for advanced thymic tumors (thymoma and thymic carcinoma) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Thymoma, Thymic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-05-30